X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 M | 2025-12-05 | ADVM | Adverum Biotechnologies, Inc. | Biological Products, (No Diagnostic Substances) | 2 | P - Purchase | $4.28 | +178,699 | 281,702 | +173% | +$764,917 | |||||
| 4 | 2025-12-05 | AEBI | Aebi Schmidt Holding AG | Construction Machinery & Equip | 4 | P - Purchase | $11.50 | +24,000 | 243,368 | +11% | +$275,907 | |||||
| 3 | 2025-12-05 | GMRE | Global Medical Reit Inc. | Real Estate Investment Trusts | 2 | P - Purchase | $32.46 | +23,000 | 61,178 | +60% | +$746,643 | |||||
| 5 | 2025-12-08 | SVCO | Silvaco Group, Inc. | Prepackaged Software | 3 | P - Purchase | $4.10 | +65,372 | 623,002 | +12% | +$268,309 | |||||
| 5 | 2025-12-04 | CFND | C1 Fund Inc. | Closed-End Funds | 2 | P - Purchase | $5.32 | +50,600 | 318,207 | +19% | +$269,005 | |||||
| 13 M | 2025-09-18 | NEXT | Nextdecade Corp | Natural Gas Transmission & Distribution | 5 | P - Purchase | $6.29 | +7,552,806 | 57,464,321 | +15% | +$47,495,190 | |||||
| 2 DM | 2025-12-02 | TENX | Tenax Therapeutics, Inc. | Pharmaceutical Preparations | 2 | P - Purchase | $7.98 | +13,000 | 15,654 | +490% | +$103,786 | |||||
| 10 M | 2025-12-03 | HYNE | Hoyne Bancorp, Inc. | Savings Institutions, Not Federally Chartered | 10 | P - Purchase | $10.50 | +231,426 | 287,094 | +416% | +$2,428,915 | |||||
| 8 M | 2025-12-03 | SELF | Global Self Storage, Inc. | Real Estate Investment Trusts | 2 | P - Purchase | $5.11 | +88,307 | 486,879 | +22% | +$451,283 | |||||
| 6 M | 2025-12-03 | FSSL | Fs Specialty Lending Fund | Closed-End Funds | 3 | P - Purchase | $13.41 | +102,283 | 189,656 | +117% | +$1,371,614 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-05 | ADVM | Adverum Biotechnologies, Inc. | Fischer Laurent | CEO, Pres, Dir | P - Purchase | $4.30 | +128,699 | 201,513 | +177% | +$553,917 | |||||
2025-12-05 | ADVM | Adverum Biotechnologies, Inc. | Soparkar Peter | COO | P - Purchase | $4.22 | +50,000 | 80,189 | +166% | +$211,000 | ||||||
2025-12-08 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $4.31 | +45,000 | 2,798,096 | +2% | +$193,794 | ||||||
| M | 2025-12-04 | TISI | Team Inc | Corre Partners Management, LLC | 10% | P - Purchase | $14.91 | +2,996 | 1,604,326 | 0% | +$44,675 | |||||
| M | 2025-12-04 | OFLX | Omega Flex, Inc. | Shea Stephen M | Dir | P - Purchase | $28.46 | +3,750 | 3,750 | New | +$106,721 | |||||
2025-12-05 | AEBI | Aebi Schmidt Holding AG | Schaub Patrick Francois | Dir | P - Purchase | $12.75 | +7,500 | 43,463 | +21% | +$95,657 | ||||||
| M | 2025-11-17 | DMAC | Diamedica Therapeutics Inc. | Stahlberg Jan | 10% | P - Purchase | $7.19 | +1,061,277 | 8,825,742 | +14% | +$7,631,469 | |||||
| M | 2025-12-04 | SRZN | Surrozen, Inc./De | Kutzkey Tim | Dir, 10% | P - Purchase | $19.22 | +36,150 | 2,196,177 | +2% | +$694,850 | |||||
| M | 2025-12-04 | SRZN | Surrozen, Inc./De | Column Group III Gp, LP | 10% | P - Purchase | $19.22 | +36,150 | 2,196,177 | +2% | +$694,850 | |||||
| M | 2025-12-05 | MDRR | Medalist Diversified Reit, Inc. | Kavanaugh Frank | COB, CEO, Pres, 10% | P - Purchase | $13.97 | +8,021 | 229,595 | +4% | +$112,027 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-05 | ADVM | Adverum Biotechnologies, Inc. | Fischer Laurent | CEO, Pres, Dir | P - Purchase | $4.30 | +128,699 | 201,513 | +177% | +$553,917 | |||||
2025-12-05 | ADVM | Adverum Biotechnologies, Inc. | Soparkar Peter | COO | P - Purchase | $4.22 | +50,000 | 80,189 | +166% | +$211,000 | ||||||
2025-12-08 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $4.31 | +45,000 | 2,798,096 | +2% | +$193,794 | ||||||
| M | 2025-12-04 | MMLP | Martin Midstream Partners L.P. | Martin Product Sales LLC | 10% | P - Purchase | $2.59 | +14,418 | 2,768,594 | +1% | +$37,354 | |||||
| M | 2025-12-04 | NXDT | Nexpoint Diversified Real Estate Trust | Laffer Arthur B | Dir | P - Purchase | $2.79 | +15,052 | 232,399 | +7% | +$42,043 | |||||
2025-12-08 | SVCO | Silvaco Group, Inc. | Zegarelli Christopher John | CFO | P - Purchase | $3.80 | +10,000 | 439,407 | +2% | +$37,950 | ||||||
2025-12-04 | NRDY | Nerdy Inc. | Cohn Charles K. | CEO, 10% | P - Purchase | $1.37 | +186,930 | 56,693,229 | 0% | +$256,094 | ||||||
2025-12-05 | SINT | Sintx Technologies, Inc. | Honigblum Gregg R. | Chief Investment Officer | P - Purchase | $3.93 | +65,000 | 192,867 | +51% | +$255,350 | ||||||
| M | 2025-12-03 | BFLY | Butterfly Network, Inc. | Robbins Larry | Dir, 10% | P - Purchase | $2.99 | +1,558,541 | 19,225,877 | +9% | +$4,652,773 | |||||
2025-12-03 | GPUS | Hyperscale Data, Inc. | Ault Milton C III | Exec COB, 10% | P - Purchase | $0.28 | +100,000 | 500,571 | +25% | +$27,770 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-05 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | S - Sale | $103.07 | -31,452 | 25,987 | -55% | -$3,241,621 | ||||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Bell Michael Brian | CFO | S - Sale+OE | $103.14 | -80,362 | 28,052 | -74% | -$8,288,742 | |||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale+OE | $107.19 | -28,611 | 9,851 | -74% | -$3,066,817 | |||||
| DM | 2025-12-05 | EOSE | Eos Energy Enterprises, Inc. | Stidolph Russell Monoki | Dir | S - Sale+OE | $14.97 | -766,134 | 2,412,628 | -24% | -$11,471,766 | |||||
| DM | 2025-12-04 | ACMR | Acm Research, Inc. | McKechnie Mark | See remarks | S - Sale+OE | $34.93 | -31,250 | 900 | -97% | -$1,091,507 | |||||
2025-12-08 | SYM | Symbotic Inc. | Softbank Group Corp. | 10% | S - Sale | $53.21 | -3,500,000 | 45,415,312 | -7% | -$186,243,750 | ||||||
2025-12-08 | SYM | Symbotic Inc. | Svf Sponsor III (De) LLC | 10% | S - Sale | $53.21 | -3,500,000 | 45,415,312 | -7% | -$186,243,750 | ||||||
| M | 2025-12-04 | BFLY | Butterfly Network, Inc. | Rothberg Jonathan M | Dir, 10% | S - Sale | $3.08 | -101,796 | 33,673,686 | 0% | -$313,064 | |||||
| D | 2025-12-05 | RUN | Sunrun Inc. | Fenster Edward Harris | Dir | S - Sale+OE | $18.11 | -133,256 | 1,474,926 | -8% | -$2,412,960 | |||||
| M | 2025-12-05 | EOSE | Eos Energy Enterprises, Inc. | Bornstein Jeffrey S | Dir | S - Sale | $15.19 | -40,328 | 117,259 | -26% | -$612,536 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-04 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | M - OptEx | $19.68 | +6,902 | 208,601 | +3% | +$135,831 | |||||
2025-12-04 | ROLR | High Roller Technologies, Inc. | Young Seth Adam | CEO | P - Purchase | $1.58 | +5,850 | 12,796 | +84% | +$9,243 | ||||||
| M | 2025-12-05 | ADVM | Adverum Biotechnologies, Inc. | Fischer Laurent | CEO, Pres, Dir | P - Purchase | $4.30 | +128,699 | 201,513 | +177% | +$553,917 | |||||
2025-12-05 | ADVM | Adverum Biotechnologies, Inc. | Soparkar Peter | COO | P - Purchase | $4.22 | +50,000 | 80,189 | +166% | +$211,000 | ||||||
2025-12-05 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | S - Sale | $103.07 | -31,452 | 25,987 | -55% | -$3,241,621 | ||||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Bell Michael Brian | CFO | M - OptEx | $30.71 | +56,287 | 28,052 | -199% | +$1,728,787 | |||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Bell Michael Brian | CFO | S - Sale+OE | $103.14 | -80,362 | 28,052 | -74% | -$8,288,742 | |||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Clark Ian T | Dir | M - OptEx | $35.83 | +28,611 | 9,851 | -153% | +$1,025,156 | |||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale+OE | $107.19 | -28,611 | 9,851 | -74% | -$3,066,817 | |||||
| D | 2025-12-05 | NOC | Northrop Grumman Corp /De/ | Roeder Roshan S | CVP, Pres Mission Systems | F - Tax | $548.97 | -159 | 602 | -21% | -$87,286 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |